ImmuCell
ICCC
22 hedge funds and large institutions have $8.86M invested in ImmuCell in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.92% less ownership
Funds ownership: 23.04% → 22.12% (-0.92%)
4% less funds holding
Funds holding: 23 → 22 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
87% less capital inflows, than outflows
Capital inflows: $61.7K | Capital outflows: $462K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$24K |
| 2 |
Morgan Stanley
New York
|
+$10.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.96K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$6.3K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$4.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Heartland Advisors
Milwaukee,
Wisconsin
|
-$144K |
| 2 |
Wexford Capital
West Palm Beach,
Florida
|
-$144K |
| 3 |
Eidelman Virant Capital
Saint Louis,
Missouri
|
-$91K |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$58.5K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$13K |
ICCC Hedge Fund Activity: Q3 2019 in Review
22 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2019, worth a combined $8.86M — down 18% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ICCC and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $24K. The largest seller was Heartland Advisors, cutting an estimated $144K.
- 22 institutional investors held ImmuCell (ICCC) as of Q3 2019, down from 23 in Q2 2019.
- Funds reported $8.86M of ImmuCell stock for Q3 2019, down 18% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q3 2019 and 2 closed out, a net change of -1 holder.
- The largest ImmuCell buyer in Q3 2019 was Renaissance Technologies, an estimated $24K added.
- The largest ImmuCell seller in Q3 2019 was Heartland Advisors, an estimated $144K sold.
Based on aggregated 13F filings for Q3 2019.